APA
Seibert T. M., Fan C. C., Wang Y., Zuber V., Karunamuni R., Parsons J. K., Eeles R. A., Easton D. F., Kote-Jarai Z., Al Olama A. A., Garcia S. B., Muir K., Grönberg H., Wiklund F., Aly M., Schleutker J., Sipeky C., Tammela T. L., Nordestgaard B. G., Nielsen S. F., Weischer M., Bisbjerg R., Røder M. A., Iversen P., Key T. J., Travis R. C., Neal D. E., Donovan J. L., Hamdy F. C., Pharoah P., Pashayan N., Khaw K., Maier C., Vogel W., Luedeke M., Herkommer K., Kibel A. S., Cybulski C., Wokolorczyk D., Kluzniak W., Cannon-Albright L., Brenner H., Cuk K., Saum K., Park J. Y., Sellers T. A., Slavov C., Kaneva R., Mitev V., Batra J., Clements J. A., Spurdle A., Teixeira M. R., Paulo P., Maia S., Pandha H., Michael A., Kierzek A., Karow D. S., Mills I. G., Andreassen O. A. & Dale A. M. (20180305). Polygenic hazard score to guide screening for aggressive prostate cancer: development and validation in large scale cohorts. : BMJ (Clinical research ed.).
Chicago
Seibert Tyler M, Fan Chun Chieh, Wang Yunpeng, Zuber Verena, Karunamuni Roshan, Parsons J Kellogg, Eeles Rosalind A, Easton Douglas F, Kote-Jarai ZSofia, Al Olama Ali Amin, Garcia Sara Benlloch, Muir Kenneth, Grönberg Henrik, Wiklund Fredrik, Aly Markus, Schleutker Johanna, Sipeky Csilla, Tammela Teuvo Lj, Nordestgaard Børge G, Nielsen Sune F, Weischer Maren, Bisbjerg Rasmus, Røder M Andreas, Iversen Peter, Key Tim J, Travis Ruth C, Neal David E, Donovan Jenny L, Hamdy Freddie C, Pharoah Paul, Pashayan Nora, Khaw Kay-Tee, Maier Christiane, Vogel Walther, Luedeke Manuel, Herkommer Kathleen, Kibel Adam S, Cybulski Cezary, Wokolorczyk Dominika, Kluzniak Wojciech, Cannon-Albright Lisa, Brenner Hermann, Cuk Katarina, Saum Kai-Uwe, Park Jong Y, Sellers Thomas A, Slavov Chavdar, Kaneva Radka, Mitev Vanio, Batra Jyotsna, Clements Judith A, Spurdle Amanda, Teixeira Manuel R, Paulo Paula, Maia Sofia, Pandha Hardev, Michael Agnieszka, Kierzek Andrzej, Karow David S, Mills Ian G, Andreassen Ole A and Dale Anders M. 20180305. Polygenic hazard score to guide screening for aggressive prostate cancer: development and validation in large scale cohorts. : BMJ (Clinical research ed.).
Harvard
Seibert T. M., Fan C. C., Wang Y., Zuber V., Karunamuni R., Parsons J. K., Eeles R. A., Easton D. F., Kote-Jarai Z., Al Olama A. A., Garcia S. B., Muir K., Grönberg H., Wiklund F., Aly M., Schleutker J., Sipeky C., Tammela T. L., Nordestgaard B. G., Nielsen S. F., Weischer M., Bisbjerg R., Røder M. A., Iversen P., Key T. J., Travis R. C., Neal D. E., Donovan J. L., Hamdy F. C., Pharoah P., Pashayan N., Khaw K., Maier C., Vogel W., Luedeke M., Herkommer K., Kibel A. S., Cybulski C., Wokolorczyk D., Kluzniak W., Cannon-Albright L., Brenner H., Cuk K., Saum K., Park J. Y., Sellers T. A., Slavov C., Kaneva R., Mitev V., Batra J., Clements J. A., Spurdle A., Teixeira M. R., Paulo P., Maia S., Pandha H., Michael A., Kierzek A., Karow D. S., Mills I. G., Andreassen O. A. and Dale A. M. (20180305). Polygenic hazard score to guide screening for aggressive prostate cancer: development and validation in large scale cohorts. : BMJ (Clinical research ed.).
MLA
Seibert Tyler M, Fan Chun Chieh, Wang Yunpeng, Zuber Verena, Karunamuni Roshan, Parsons J Kellogg, Eeles Rosalind A, Easton Douglas F, Kote-Jarai ZSofia, Al Olama Ali Amin, Garcia Sara Benlloch, Muir Kenneth, Grönberg Henrik, Wiklund Fredrik, Aly Markus, Schleutker Johanna, Sipeky Csilla, Tammela Teuvo Lj, Nordestgaard Børge G, Nielsen Sune F, Weischer Maren, Bisbjerg Rasmus, Røder M Andreas, Iversen Peter, Key Tim J, Travis Ruth C, Neal David E, Donovan Jenny L, Hamdy Freddie C, Pharoah Paul, Pashayan Nora, Khaw Kay-Tee, Maier Christiane, Vogel Walther, Luedeke Manuel, Herkommer Kathleen, Kibel Adam S, Cybulski Cezary, Wokolorczyk Dominika, Kluzniak Wojciech, Cannon-Albright Lisa, Brenner Hermann, Cuk Katarina, Saum Kai-Uwe, Park Jong Y, Sellers Thomas A, Slavov Chavdar, Kaneva Radka, Mitev Vanio, Batra Jyotsna, Clements Judith A, Spurdle Amanda, Teixeira Manuel R, Paulo Paula, Maia Sofia, Pandha Hardev, Michael Agnieszka, Kierzek Andrzej, Karow David S, Mills Ian G, Andreassen Ole A and Dale Anders M. Polygenic hazard score to guide screening for aggressive prostate cancer: development and validation in large scale cohorts. : BMJ (Clinical research ed.). 20180305.